论文信息 - First experience of photodithazine clinical application for photodynamic therapy of malignant tumors

First experience of photodithazine clinical application for photodynamic therapy of malignant tumors

In 1998 a new second-generation photosensitizer was introduced in Russia - a chlorine derivative named Photodithazine - water-soluble preparation with absorption peak at 668 nm. This novel preparation has passed pre- clinical in vitro and in vivo studies. In 1999 a limited series of clinical testing of photodynamic therapy with photodithazine has been performed in the State Research Center for Laser Medicine of Russian Ministry of Public Health.

[1] Eugeny Ph. Stranadko,et al. Photodynamic therapy of human malignant tumors: a comparative study between photohem and tetrasulfonated aluminum phthalocyanine , 1996, European Conference on Biomedical Optics.

[2] Andrei F. Mironov,et al. Photodynamic therapy of cancer: five-year clinical experience , 1997, European Conference on Biomedical Optics.

[3] G A Kostenich,et al. Experimental grounds for using chlorin e6 in the photodynamic therapy of malignant tumors. , 1994, Journal of photochemistry and photobiology. B, Biology.

[4] Eugeny Ph. Stranadko,et al. Pecularities of clinical photodynamic therapy of cancer , 1996, Other Conferences.

[5] G. Gurinovich,et al. Photodynamic activity of chlorin e6 and chlorin e6 ethylenediamide in vitro and in vivo. , 1992, Journal of photochemistry and photobiology. B, Biology.

[6] Kevin M. Smith,et al. CHLORIN AND PORPHYRIN DERIVATIVES AS POTENTIAL PHOTOSENSITIZERS IN PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[7] C J Gomer,et al. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. , 1990, Cancer research.